by Robert S. Miller. Dr. Gabriel Hortobagyi discusses the 2011 update of the ASCO guideline on the use of bone-modifying agents in patients with metastatic breast cancer.
don't worry if you don't have an account with us, we'll create one
[{"meta":{"author":"JCO Oncology Practice Podcast","authorlink":""},"src":"http:\/\/traffic.libsyn.com\/joppodcast\/jop-podcast-4-11-2011.mp3?dest-id=230206","thumb":{"src":"https:\/\/lystnimg.b-cdn.net\/podcastsnw-202207\/dd80b3-ab36-6174-915d2c_800.png"},"title":"Bone-Modifying Agents in Metastatic Breast Cancer","link":"javascript:;","id":"item-259925"}]
